| Released | Contributor | Author | Title | Pages | Price |
|---|
| May 26, 2013 | Pechala's Reports | Lubomir Pechala | ACURA PHARMACEUTICALS INC (ACUR) - REPORT FOR ACTIVE TRADERS | 1 | $25 | | May 24, 2013 | S&P Capital IQ Quantitative Report | N/A | Acura Pharmaceuticals | 6 | $69 | | May 24, 2013 | Pechala's Reports | Frantisek Pechala | ACURA PHARMACEUTICALS INC (ACUR) 12-months forecast | 1 | $15 | | May 23, 2013 | Jefferson Research | N/A | Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ACURA PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. | 11 | $20 | | May 23, 2013 | Ford Investor Services, Inc. | N/A | Industry Value Graph: ACUR , ANTH , LCI , OMER , PIP , SLXP -- DRUGS | 3 | $34.50 | | May 23, 2013 | Ford Investor Services, Inc. | N/A | Value Graph: ACURA PHARMACEUT -- ACUR | 1 | $11.50 | | May 22, 2013 | ValuEngine, Inc. | N/A | ValuEngine Detailed Valuation Report for ACUR | 11 | $126.50 | | May 17, 2013 | Wright Reports | N/A | Wright Investors Service Comprehensive Report for Acura Pharmaceuticals, Inc. | 41 | $471.50 | | May 2, 2013 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for Medical-generic Drugs | 17 | $195.50 |
|
View All Reports for ACUR ... |
|
|
0.01(0.42%) May 24, 4:00PM EDT